CRISPR市場規模、佔有率和成長分析：按應用、技術、產品、最終用戶和地區分類－2026-2033年產業預測

2024 年全球 CRISPR 市場價值為 38.2 億美元，預計到 2033 年將從 2025 年的 45.6 億美元成長到 188.5 億美元，預測期（2026-2033 年）的複合年成長率為 19.32%。

全球CRISPR市場的發展動力源自於基因編輯技術創新成果在實際治療與商業應用的快速轉換。這個多元化市場涵蓋了研究、臨床治療、農業和診斷等領域的工具、服務、平台和終端應用。其重要性在於能夠加速改變疾病進程的療法研發，縮短研發週期，並推出突破性產品。推動市場成長的關鍵因素包括臨床檢驗、投資者資金和產業合作，這些環節將科學進步轉化為可擴展的解決方案。成功的臨床試驗能增強投資者信心，並促成Vertex與CRISPR Therapeutics等公司的大規模合作。這些合作最佳化了平台，提升了生產能力，從而降低了成本並加快了法規核准流程。

全球CRISPR市場成長要素

全球CRISPR市場正經歷顯著成長，這主要得益於CRISPR技術在包括遺傳疾病、癌症治療和病毒感染疾病在內的多個治療領域的快速發展。隨著CRISPR應用範圍的不斷擴大，基因組編輯領域湧現新的機遇，包括相關工具、試劑和服務。研究人員日益致力於將科學發現轉化為實際治療方法，促使製藥公司和臨床研究人員對CRISPR應用產生了濃厚的興趣。因此，CRISPR技術在臨床前和轉化研究中的應用進一步提升了對專業CRISPR資源和工具的需求，從而推動了市場成長。

全球CRISPR市場面臨的限制因素

由於法律規範的不確定性以及圍繞生殖細胞編輯、人類應用和潛在生態系統影響的持續倫理辯論，全球CRISPR市場面臨嚴峻挑戰。這往往導致開發者、投資者和臨床相關人員者猶豫不決，從而延遲專案啟動並限制商業策略。冗長的審查流程以及適應不斷變化的政策預期，都要求企業投入大量精力進行合規性審查，這可能會影響產品線優先順序的策略決策。因此，這種謹慎的市場環境可能會減緩產品向臨床應用的推進速度，降低某些領域的投資意願，並因區域要求的差異而導致市場分散。

全球CRISPR市場趨勢

全球CRISPR市場目前正經歷一場變革，其驅動力在於遞送平台技術的進步，這些進步顯著提升了基因編輯技術的精準性和特異性。載體設計、奈米顆粒化學和製劑策略的創新正在顯著提高CRISPR遞送系統的效率，從而減少脫靶效應並擴大其適用範圍。這一發展趨勢正在加速CRISPR技術在臨床領域的應用，並促進基因編輯公司與遞送技術專家之間的合作。因此，市場關注正從核心酵素產品轉向整合遞送解決方案，從而促進更有效率的研發流程，加速CRISPR技術在治療和研究領域的應用，並拓展商業性機會。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球 CRISPR 市場規模：按應用領域分類

• 基因組編輯
• 診斷（夏洛克，偵探）
• 農業生物技術
• 藥物研發

全球CRISPR市場規模：依技術分類

• CRISPR-Cas9
• CRISPR-Cas12
• 基礎編輯
• Prime Edit

全球 CRISPR 市場規模：依產品分類

• 裝置
• 試劑和試劑盒
• 服務

全球 CRISPR 市場規模：依最終用戶分類

• 製藥和生物技術
• 研究機構
• 農業生物技術
• 臨床診斷

全球CRISPR市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Editas Medicine
• Intellia Therapeutics
• CRISPR Therapeutics
• Beam Therapeutics
• Prime Medicine
• Caribou Biosciences
• Inscripta Inc.
• Arbor Biotechnologies
• Sherlock Biosciences
• Mammoth Biosciences
• ERS Genomics
• Horizon Discovery（PerkinElmer）
• GenScript Biotech
• Synthego Corporation
• Integrated DNA Technologies
• Addgene
• Cellectis SA
• Precision BioSciences
• Sangamo Therapeutics
• Agilent Technologies

結論與建議

Global Crispr Market size was valued at USD 3.82 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 18.85 Billion by 2033, growing at a CAGR of 19.32% during the forecast period (2026-2033).

The global CRISPR market is driven by the rapid translation of gene-editing innovations into viable therapeutic and commercial applications. This diverse market includes tools, services, platforms, and end-use applications across research, clinical therapies, agriculture, and diagnostics. The significance of this market lies in its ability to facilitate disease-modifying treatments, shorten R&D cycles, and introduce groundbreaking products. A crucial factor boosting growth is the cycle of clinical validation, investor funding, and industrial partnerships that transform scientific advancements into scalable solutions. Successful clinical trials build investor confidence, leading to larger collaborations like those between Vertex and CRISPR Therapeutics, which optimize platforms and enhance manufacturing capabilities, thereby reducing costs and expediting regulatory approvals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Crispr market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Crispr Market Segments Analysis

Global CRISPR market is segmented by application, technology, product, end-user and region. Based on application, the market is segmented into Genome Editing, Diagnostics (SHERLOCK, DETECTR), Agricultural Biotechnology and Drug Development. Based on technology, the market is segmented into CRISPR-Cas9, CRISPR-Cas12, Base Editing and Prime Editing. Based on product, the market is segmented into Instruments, Reagents & Kits and Services. Based on end-user, the market is segmented into Pharma & Biotech, Research Institutes, Agri-Biotech and Clinical Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Crispr Market

The global CRISPR market is experiencing significant growth driven by the rapid evolution of CRISPR technologies across various therapeutic fields, including genetic disorders, cancer treatment, and viral infections. As the application of CRISPR expands, it is fostering new opportunities within the genome editing domain, encompassing tools, reagents, and associated services. Researchers are increasingly focused on translating scientific discoveries into viable treatments, prompting heightened interest from pharmaceutical companies and clinical researchers in CRISPR applications. This integration of CRISPR into preclinical and translational research further amplifies the demand for specialized CRISPR resources and tools, thereby propelling the growth of the market.

Restraints in the Global Crispr Market

The global CRISPR market faces significant challenges due to uncertainty surrounding regulatory frameworks and ongoing ethical discussions related to germline editing, human applications, and potential ecological impacts. This creates hesitation among developers, investors, and clinical stakeholders, often resulting in delays for project initiation and restricting commercial strategies. The complexity of lengthy review processes and the need to adapt to changing policy expectations necessitate substantial compliance efforts, which can shape strategic decisions regarding pipeline priorities. Consequently, this cautious atmosphere slows down the advancement of products toward clinical applications, diminishes investment interest in specific areas, and may lead to a fragmented market due to varying requirements across regions.

Market Trends of the Global Crispr Market

The Global CRISPR market is currently witnessing a transformative shift driven by advancements in delivery platforms that enhance the precision and specificity of gene editing technologies. Innovations in vector design, nanoparticle chemistry, and formulation strategies are significantly improving the effectiveness of CRISPR delivery systems, thereby reducing off-target effects and widening the spectrum of applicable indications. This evolution is fostering increased clinical adoption and encouraging collaborations between gene editing firms and delivery technology specialists. Consequently, the market's focus is transitioning from core enzyme products to integrated delivery solutions, promoting more efficient development processes, expediting adoption in therapeutic and research environments, and boosting commercial opportunities.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global CRISPR Market Size by Application & CAGR (2026-2033)

• Market Overview
• Genome Editing
• Diagnostics (SHERLOCK, DETECTR)
• Agricultural Biotechnology
• Drug Development

Global CRISPR Market Size by Technology & CAGR (2026-2033)

• Market Overview
• CRISPR-Cas9
• CRISPR-Cas12
• Base Editing
• Prime Editing

Global CRISPR Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Services

Global CRISPR Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma & Biotech
• Research Institutes
• Agri-Biotech
• Clinical Diagnostics

Global CRISPR Market Size & CAGR (2026-2033)

• North America (Application, Technology, Product, End-User)
  • US
  • Canada
• Europe (Application, Technology, Product, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Technology, Product, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Technology, Product, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Technology, Product, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Editas Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inscripta Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arbor Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sherlock Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision BioSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations